insights_auto
Why is GH up 2.54%?
Dive Deeperchevron_right
GH:NASDAQ
Guardant Health Inc
US$182.59
arrow_upward
+2.54%(+4.53) 1D
US$181.07
arrow_downward
-0.83% (-1.52)bedtimeAfter hours
Closed: ኦክቶ 28, 4:00:01 ከሰዓት ጂ ኤም ቲ-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GH...
Open
US$178.06
High
US$186.03
Low
US$177.00
Mkt. cap
24.50 ቢ
Avg. vol.
1.85 ሚ
Volume
185.00
52-wk high
US$191.01
52-wk low
US$68.02
EPS
-US$3.50
Beta
1.58
Shares outstanding
134.20 ሚ
No. of employees
2 ሺ
Open
US$178.06
High
US$186.03
Low
US$177.00
Mkt. cap
24.50 ቢ
Avg. vol.
1.85 ሚ
Volume
185.00
52-wk high
US$191.01
52-wk low
US$68.02
EPS
-US$3.50
Beta
1.58
Shares outstanding
134.20 ሚ
No. of employees
2 ሺ
News stories
From web sources and news partners
Investing.com
·
ከ1 ቀን በፊት
BTIG raises Guardant Health stock price target on growth outlook
Profile
Guardant Health, Inc. is an American biotechnology company based in Palo Alto, California. Co-founders Helmy Eltoukhy and AmirAli Talasaz serve as co-chief executive officers. Wikipedia
About Guardant Health Inc
CEOHelmy Eltoukhy | AmirAli Talasaz
Employees2.5 ሺ
Founded2012
HeadquartersPalo Alto, ካሊፎርኒያ, ዩናይትድ ስቴትስ
SectorHealth care provider
Websiteguardanthealth.com